Experience
Advised a global pharma company on loss of exclusivity and enforcement strategy in relation to its platelet inhibitor drug*
Advised a global pharma company on loss of exclusivity and enforcement strategy in relation to its platelet inhibitor drug.
*Matter handled prior to joining Finnegan.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.